Jupiter Orphan Therapeutics

601 Heritage Drive
Suite 137
United States

Tel: 561-308-7780

Email: info@jupiterorphan.com

Show jobs for this employer

About Jupiter Orphan Therapeutics

Jupiter Orphan Therapeutics (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal office located in Jupiter, FL, USA, was founded in the summer of 2015. In its short period of operations, JOT has assembled a very strong management and scientific team as well as defined five pipeline products which of one is already in Phase II.
Founder and CEO: Christer Rosén
CFO: Jacob Uittenbogaard
Co-Founder and CMO: Dr. Claes Wahlestedt, MD, Ph.D.
CSO: Marshall Hayward
VP of Science Research: Shaun P Brothers, Ph.D. ?? PIPELINE:
Please click here for Jupiter Orphan Therapeutics' pipeline.

17 articles with Jupiter Orphan Therapeutics